nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—Lisinopril—dilated cardiomyopathy	0.279	0.532	CbGbCtD
Silodosin—ABCB1—Spironolactone—dilated cardiomyopathy	0.246	0.468	CbGbCtD
Silodosin—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0235	0.0966	CcSEcCtD
Silodosin—Drug eruption—Furosemide—dilated cardiomyopathy	0.0128	0.0526	CcSEcCtD
Silodosin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00834	0.0343	CcSEcCtD
Silodosin—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00728	0.0299	CcSEcCtD
Silodosin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00638	0.0262	CcSEcCtD
Silodosin—Purpura—Furosemide—dilated cardiomyopathy	0.00592	0.0244	CcSEcCtD
Silodosin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00521	0.0214	CcSEcCtD
Silodosin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.0049	0.0201	CcSEcCtD
Silodosin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0047	0.0193	CcSEcCtD
Silodosin—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00461	0.019	CcSEcCtD
Silodosin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00445	0.0183	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00425	0.0175	CcSEcCtD
Silodosin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00416	0.0171	CcSEcCtD
Silodosin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00409	0.0168	CcSEcCtD
Silodosin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00391	0.0161	CcSEcCtD
Silodosin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00387	0.0159	CcSEcCtD
Silodosin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00383	0.0157	CcSEcCtD
Silodosin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00365	0.015	CcSEcCtD
Silodosin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00358	0.0147	CcSEcCtD
Silodosin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00356	0.0147	CcSEcCtD
Silodosin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00353	0.0145	CcSEcCtD
Silodosin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00341	0.014	CcSEcCtD
Silodosin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00341	0.014	CcSEcCtD
Silodosin—Rash—Spironolactone—dilated cardiomyopathy	0.00325	0.0134	CcSEcCtD
Silodosin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00325	0.0134	CcSEcCtD
Silodosin—Headache—Spironolactone—dilated cardiomyopathy	0.00323	0.0133	CcSEcCtD
Silodosin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00321	0.0132	CcSEcCtD
Silodosin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00312	0.0128	CcSEcCtD
Silodosin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00309	0.0127	CcSEcCtD
Silodosin—Nausea—Spironolactone—dilated cardiomyopathy	0.00306	0.0126	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0029	0.0119	CcSEcCtD
Silodosin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00286	0.0118	CcSEcCtD
Silodosin—ABCB4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00279	0.012	CbGpPWpGaD
Silodosin—Shock—Furosemide—dilated cardiomyopathy	0.00276	0.0113	CcSEcCtD
Silodosin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00275	0.0113	CcSEcCtD
Silodosin—ADRA1D—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00274	0.0118	CbGpPWpGaD
Silodosin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00272	0.0112	CcSEcCtD
Silodosin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00269	0.0111	CcSEcCtD
Silodosin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00267	0.011	CcSEcCtD
Silodosin—Hypotension—Furosemide—dilated cardiomyopathy	0.00262	0.0108	CcSEcCtD
Silodosin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00259	0.0107	CcSEcCtD
Silodosin—ADRA1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00249	0.0107	CbGpPWpGaD
Silodosin—ADRA1A—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.00249	0.0107	CbGpPWpGaD
Silodosin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00242	0.00996	CcSEcCtD
Silodosin—ADRA1B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00236	0.0101	CbGpPWpGaD
Silodosin—Syncope—Lisinopril—dilated cardiomyopathy	0.00231	0.00951	CcSEcCtD
Silodosin—ADRA1D—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0023	0.00988	CbGpPWpGaD
Silodosin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00229	0.00943	CcSEcCtD
Silodosin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00228	0.00937	CcSEcCtD
Silodosin—ADRA1B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00227	0.00976	CbGpPWpGaD
Silodosin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00226	0.00932	CcSEcCtD
Silodosin—Urticaria—Furosemide—dilated cardiomyopathy	0.00223	0.00916	CcSEcCtD
Silodosin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00222	0.00912	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00218	0.00897	CcSEcCtD
Silodosin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00215	0.00883	CcSEcCtD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00214	0.00919	CbGpPWpGaD
Silodosin—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00214	0.00918	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00209	0.00899	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00208	0.00894	CbGpPWpGaD
Silodosin—Shock—Lisinopril—dilated cardiomyopathy	0.00207	0.00851	CcSEcCtD
Silodosin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00205	0.00845	CcSEcCtD
Silodosin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00204	0.00841	CcSEcCtD
Silodosin—ADRA1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00202	0.00867	CbGpPWpGaD
Silodosin—Asthenia—Furosemide—dilated cardiomyopathy	0.00201	0.00828	CcSEcCtD
Silodosin—Pruritus—Furosemide—dilated cardiomyopathy	0.00198	0.00816	CcSEcCtD
Silodosin—Hypotension—Lisinopril—dilated cardiomyopathy	0.00197	0.00809	CcSEcCtD
Silodosin—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00192	0.00826	CbGpPWpGaD
Silodosin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00192	0.00789	CcSEcCtD
Silodosin—ADRA1B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00191	0.0082	CbGpPWpGaD
Silodosin—Insomnia—Lisinopril—dilated cardiomyopathy	0.0019	0.00783	CcSEcCtD
Silodosin—Dizziness—Furosemide—dilated cardiomyopathy	0.00185	0.00763	CcSEcCtD
Silodosin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00182	0.00747	CcSEcCtD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00177	0.00762	CbGpPWpGaD
Silodosin—Rash—Furosemide—dilated cardiomyopathy	0.00177	0.00727	CcSEcCtD
Silodosin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00177	0.00727	CcSEcCtD
Silodosin—Headache—Furosemide—dilated cardiomyopathy	0.00176	0.00723	CcSEcCtD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00173	0.00742	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00172	0.00741	CbGpPWpGaD
Silodosin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00172	0.00708	CcSEcCtD
Silodosin—ADRA1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0017	0.00729	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ANKRD1—dilated cardiomyopathy	0.00168	0.00724	CbGpPWpGaD
Silodosin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00167	0.00688	CcSEcCtD
Silodosin—Nausea—Furosemide—dilated cardiomyopathy	0.00166	0.00685	CcSEcCtD
Silodosin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00166	0.00684	CcSEcCtD
Silodosin—ABCB4—Metabolism—TAZ—dilated cardiomyopathy	0.00158	0.0068	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00158	0.00677	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00155	0.00666	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00153	0.00659	CbGpPWpGaD
Silodosin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00151	0.00621	CcSEcCtD
Silodosin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00149	0.00612	CcSEcCtD
Silodosin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00144	0.00592	CcSEcCtD
Silodosin—ABCB4—Metabolism—SDHA—dilated cardiomyopathy	0.00143	0.00615	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00143	0.00615	CbGpPWpGaD
Silodosin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00139	0.00572	CcSEcCtD
Silodosin—Rash—Lisinopril—dilated cardiomyopathy	0.00133	0.00546	CcSEcCtD
Silodosin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00132	0.00545	CcSEcCtD
Silodosin—Headache—Lisinopril—dilated cardiomyopathy	0.00132	0.00542	CcSEcCtD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00127	0.00546	CbGpPWpGaD
Silodosin—Nausea—Lisinopril—dilated cardiomyopathy	0.00125	0.00514	CcSEcCtD
Silodosin—ADRA1D—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00122	0.00522	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.0011	0.00473	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00108	0.00465	CbGpPWpGaD
Silodosin—ADRA1A—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00104	0.00446	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.00104	0.00446	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00101	0.00435	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00096	0.00413	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000914	0.00393	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000873	0.00375	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00085	0.00366	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000839	0.00361	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000834	0.00359	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000819	0.00352	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000812	0.00349	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000807	0.00347	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000766	0.00329	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000745	0.0032	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000724	0.00311	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00072	0.00309	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000693	0.00298	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00068	0.00292	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000679	0.00292	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000673	0.00289	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000652	0.0028	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000644	0.00277	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00062	0.00266	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00062	0.00266	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000615	0.00264	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000604	0.0026	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000601	0.00258	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000597	0.00257	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000581	0.0025	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000576	0.00248	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000569	0.00245	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000558	0.0024	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000558	0.0024	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000556	0.00239	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.000546	0.00235	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000541	0.00232	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000534	0.0023	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000533	0.00229	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000531	0.00228	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000529	0.00227	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000528	0.00227	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000515	0.00221	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000515	0.00221	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.00051	0.00219	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000507	0.00218	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000496	0.00213	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	0.000494	0.00212	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00048	0.00206	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000478	0.00206	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000477	0.00205	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000475	0.00204	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000472	0.00203	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000472	0.00203	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000472	0.00203	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000463	0.00199	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000462	0.00199	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000457	0.00196	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000457	0.00196	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000453	0.00195	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000452	0.00194	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000439	0.00189	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000438	0.00188	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000425	0.00183	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000425	0.00183	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00042	0.00181	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000412	0.00177	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00041	0.00176	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000396	0.0017	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000392	0.00168	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000392	0.00168	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000389	0.00167	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GPX1—dilated cardiomyopathy	0.000389	0.00167	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CD36—dilated cardiomyopathy	0.000379	0.00163	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000376	0.00162	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000375	0.00161	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000373	0.00161	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000364	0.00157	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000363	0.00156	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000353	0.00152	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000351	0.00151	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000348	0.0015	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000348	0.0015	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000344	0.00148	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AGT—dilated cardiomyopathy	0.000341	0.00147	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000335	0.00144	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000334	0.00144	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000333	0.00143	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00033	0.00142	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000324	0.00139	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000321	0.00138	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000321	0.00138	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000314	0.00135	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000313	0.00135	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000301	0.0013	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000298	0.00128	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000286	0.00123	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000278	0.0012	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000268	0.00115	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000267	0.00115	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000267	0.00115	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000261	0.00112	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000261	0.00112	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000255	0.0011	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000254	0.00109	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000252	0.00108	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000248	0.00107	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000247	0.00106	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000247	0.00106	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000242	0.00104	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000242	0.00104	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00024	0.00103	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000232	0.000996	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000225	0.000968	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000221	0.000952	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000221	0.000952	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000218	0.000938	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000217	0.000931	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000217	0.000931	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000216	0.000927	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000212	0.000911	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000206	0.000885	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000205	0.000882	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000204	0.000875	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000201	0.000864	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000201	0.000864	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000199	0.000857	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000197	0.000845	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000197	0.000845	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000195	0.000837	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000188	0.00081	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000187	0.000804	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000186	0.000801	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000184	0.000792	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000183	0.000786	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000181	0.000778	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000179	0.000769	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000179	0.000768	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000179	0.000768	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000177	0.000761	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000177	0.00076	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00017	0.000732	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000166	0.000714	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000164	0.000704	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000162	0.000694	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000161	0.000693	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000161	0.000691	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000159	0.000683	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000155	0.000665	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000151	0.00065	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000151	0.00065	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000147	0.000631	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000144	0.000621	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000143	0.000617	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000143	0.000615	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000143	0.000615	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000137	0.00059	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000137	0.00059	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	0.000134	0.000577	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000134	0.000575	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000133	0.000574	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000133	0.000572	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000131	0.000564	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	0.000131	0.000562	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00013	0.00056	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000129	0.000554	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000125	0.000539	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000125	0.000539	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00012	0.000515	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000119	0.000511	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000119	0.000511	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000119	0.000511	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	0.000118	0.000506	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000114	0.00049	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000113	0.000488	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000112	0.000483	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000111	0.000479	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00011	0.000475	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00011	0.000473	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000109	0.000468	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000107	0.00046	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000107	0.00046	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000106	0.000458	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000106	0.000454	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000106	0.000454	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000104	0.000449	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000101	0.000435	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.81e-05	0.000422	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.66e-05	0.000415	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.5e-05	0.000408	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.13e-05	0.000393	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.1e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.97e-05	0.000386	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.67e-05	0.000373	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.11e-05	0.000349	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	8.11e-05	0.000348	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	7.74e-05	0.000333	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.7e-05	0.000331	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.55e-05	0.000325	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.45e-05	0.00032	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	6.73e-05	0.000289	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.71e-05	0.000288	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.61e-05	0.000284	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.5e-05	0.000279	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	6.43e-05	0.000276	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.24e-05	0.000268	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.98e-05	0.000257	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.71e-05	0.000245	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	5.37e-05	0.000231	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.18e-05	0.000223	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	5e-05	0.000215	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.87e-05	0.000209	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.6e-05	0.000198	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	4.46e-05	0.000192	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.39e-05	0.000189	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.96e-05	0.00017	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	3.69e-05	0.000158	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.08e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.06e-05	0.000131	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3e-05	0.000129	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.72e-05	0.000117	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.7e-05	0.000116	CbGpPWpGaD
